In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Generic-drug makers are poised to flood these markets with inexpensive products. Industry ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. A similar scenario is now ...

THERE is a growing need to raise awareness about the effectiveness of generic drugs amid the increasing cost of healthcare. A 2022 survey by the UCSI Poll Research Centre survey involving 1,060 ...

Gilead Sciences, Inc. (NASDAQ:GILD) on Monday entered into settlement agreements to resolve the patent litigations with Lupin Ltd., Cipla Ltd. and Laurus Labs Ltd., generic manufacturers that filed ...

This latest FDA program aims to provide speedier reviews for generic drugmakers who produce their products in the U.S. Keeping up its string of pilots in recent months, the FDA on Friday unwrapped a ...

A new analysis from GoodRx explores how 2025 is shaping up for Food and Drug Administration drug approvals, and the early data tells a mixed story. Importantly, a growing disconnect remains between ...

Generic brands, sometimes referred to as "private label" or "store brands," are increasingly popular today as shoppers face rising food prices in grocery stores. Some consumers believe these brands to ...

Hello, and welcome to a health podocy. I'm your host, Rob Lott. I'll admit that I have a relatively simple understanding of the relationship between brand name drugs and generic drugs. Generally, I ...